TNFSF13B and non-Hodgkin lymphoma: Rosenblum and colleagues have demonstrated that a recombinant BLyS-gelonin fusion toxin (rGel/BLyS) is highly cytotoxic against malignant NHL cell lines, especially MCLs and DLBCLs [27], [28].